Stealth BioTherapeutics is a privately held clinical-stage biotechnology company focused on the development of therapeutics for diseases involving mitochondrial dysfunction.
Location: United States, Massachusetts, Needham
Employees: 51-200
Founded date: 2007
Investors 2
Date | Name | Website |
- | Hercules C... | htgc.com |
- | Horizon Te... | horizontec... |
Mentions in press and media 24
Date | Title | Description | Source |
12.02.2022 | Stealth BioTherapeutics Receives Nasdaq Notification Regardi... | BOSTON, Feb. 11, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage b... | marketscre... |
08.02.2022 | Stealth BioTherapeutics Announces Oral Presentation of New D... | BOSTON, Feb. 8, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b... | marketscre... |
20.10.2021 | Stealth BioTherapeutics : Receives Refusal to File Letter fr... | BOSTON, Oct. 20, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage ... | marketscre... |
14.09.2021 | Aduhelm backlash threatens to reverse progress in FDA’s revi... | The FDA’s approval of Aduhelm to treat Alzheimer’s disease has unleashed criticism about the decisio... | statnews.c... |
25.08.2021 | BSF Statement on Stealth BioTherapeutics’ U.S. FDA Submissio... | BOSTON (PRWEB) August 25, 2021 The Barth Syndrome Foundation (BSF) expresses immense gratitude to St... | prweb.com/... |
01.06.2021 | STEALTH BIOTHERAPEUTICS CORP Stealth BioTherapeutics : Rece... | BOSTON, June 1, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b... | marketscre... |
01.06.2021 | Stealth BioTherapeutics Receives Orphan Drug Designation fro... | prnewswire... | |
18.05.2021 | STEALTH BIOTHERAPEUTICS CORP Stealth BioTherapeutics : Anno... | BOSTON, May 17, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage b... | marketscre... |
17.05.2021 | Stealth BioTherapeutics Announces Poster Presentation at Ame... | prnewswire... | |
17.05.2021 | Stealth BioTherapeutics Announces Additional Development Fin... | prnewswire... |
Show more